secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2021-11-23T23:59:59+00:00
Accession:  0001437749-21-027323
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AcelRx appoints Jill Broadfoot as Class I director; board size set to ten
-------------------------------------------------------------------------

- Jill Broadfoot appointed to AcelRx board effective Nov 20, 2021; serves on Audit Committee.
- Board size fixed at ten directors (4 Class I, 3 Class II, 3 Class III).
- Broadfoot receives option for 30,000 shares at $0.7192 and 15,000 RSUs per director compensation policy.
- Broadfoot is CFO of aTyr Pharma and formerly CFO of Vical, with audit and finance background.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774921027323/0001437749-21-027323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774921027323/acrx20211123_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-027323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer